Literature DB >> 8572926

Comparative effects of two dithiocarbamates disulfiram and thiram, on adrenal catecholamine content and on plasma dopamine-beta-hydroxylase activity.

S Caroldi1, P De Paris.   

Abstract

Both disulfiram (tetraethylthiuram disulfide), an alcohol aversive drug, and thiram (tetramethyl-thiuram disulfide), a widely used pesticide, significantly increased the dopamine pool in the adrenal glands of dosed rats. The dopamine increase was detectable within 4 h of oral dosing with 100 mg/kg of either dithiocarbamate and peaked 24 h later at 10 times control values. In control rats the dopamine turnover was 0.51 h-1 as calculated by the assumed first order decline of dopamine after a single injection of alpha-methyl-p-tyrosine (alpha-MT, 400 mg/kg i.p.) resulting in a dopamine-beta-hydroxylase (DBH) activity of 0.73 nmol/h per pair of adrenals. In the adrenals of rats pretreated with thiram and then injected with alpha-MT, the adrenal dopamine content did not significantly decline, indicating that thiram reduced the conversion of dopamine to noradrenaline, eventually leading to the observed dopamine increase. Plasma DBH activity was significantly reduced 4 h and 24 h after dosing with thiram, but was unchanged after treatment with disulfiram. The determination of plasma DBH activity could be a marker to monitor the effect of thiram on catecholamine metabolism in occupationally exposed workers but not that of disulfiram in abstinent alcoholics.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8572926     DOI: 10.1007/s002040050233

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  14 in total

1.  Bis-(diethyldithiocarbamato) copper complex: a new metabolite of disulfiram?

Authors:  B Johansson; Z Stankiewicz
Journal:  Biochem Pharmacol       Date:  1985-08-15       Impact factor: 5.858

2.  Carbon disulfide. II. A proposed mechanism for the action of carbon disulfide on dopamine beta-hydroxylase.

Authors:  M J McKenna; V DiStefano
Journal:  J Pharmacol Exp Ther       Date:  1977-08       Impact factor: 4.030

3.  A simple and sensitive assay for dopamine-beta-hydroxylase activity by dual-wavelength spectrophotometry.

Authors:  T Kato; H Kuzuya; T Nagatsu
Journal:  Biochem Med       Date:  1974-08

4.  Effects of tetramethylthiuram disulfide and structurally-related compounds on the dopamine-beta-hydroxylase activity in the rat and hamster.

Authors:  W Lippmann; K Lloyd
Journal:  Arch Int Pharmacodyn Ther       Date:  1971-02

5.  Effects of disulfiram on serum dopamine-beta-hydroxylase and blood carbon disulphide concentrations in alcoholics.

Authors:  S Caroldi; P De Paris; S Zotti; I Zanella; F Brugnone
Journal:  J Appl Toxicol       Date:  1994 Mar-Apr       Impact factor: 3.446

Review 6.  The clinical and experimental aspects of carbon disulphide intoxication.

Authors:  L Magos
Journal:  Rev Environ Health       Date:  1975       Impact factor: 3.458

Review 7.  Regulation of the adrenal medulla.

Authors:  A Ungar; J H Phillips
Journal:  Physiol Rev       Date:  1983-07       Impact factor: 37.312

8.  Increased sympathetic nervous system activity in alcoholic patients treated with disulfiram.

Authors:  C R Lake; L F Major; M G Ziegler; I J Kopin
Journal:  Am J Psychiatry       Date:  1977-12       Impact factor: 18.112

9.  In vivo inhibition of serum dopamine-beta-hydroxylase by CaNa2 EDTA injection.

Authors:  P De Paris; S Caroldi
Journal:  Hum Exp Toxicol       Date:  1994-04       Impact factor: 2.903

10.  Disulfiram toxicity and carbon disulfide poisoning.

Authors:  J M Rainey
Journal:  Am J Psychiatry       Date:  1977-04       Impact factor: 18.112

View more
  2 in total

Review 1.  Pharmacotherapies for cocaine dependence.

Authors:  G O'Leary; R D Weiss
Journal:  Curr Psychiatry Rep       Date:  2000-12       Impact factor: 5.285

Review 2.  [New developments in the pharmacotherapy of cocaine dependence].

Authors:  G Wiesbeck; K Dürsteler-MacFarland
Journal:  Nervenarzt       Date:  2006-09       Impact factor: 1.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.